Merck Life Science inks MoU with Genext Genomics
19 November 2024 | News
Combining local expertise with global biomanufacturing capabilities
Merck Life Science in India has signed a Memorandum of Understanding (MoU) with GeNext Genomics, an emerging biotech company.
The MoU was signed between Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr Ashwin Kashikar, Managing Director, Genext Genomics; Supriya Kashikar, Founder & CEO, GeNext Genomics and Ravi Kashikar, Chairman and Founder of Ankur Seeds.
This collaboration creates a unique competitive edge by combining local expertise with global biomanufacturing capabilities. By partnering with Merck for their world-class expertise in biomanufacturing, Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem.
